Mark Hamalainen | A Coherent, Executable Plan to Achieve Unlimited Healthy Lifespan
Jan 5, 2024
auto_awesome
Mark Hamalainen, cofounder of the Longevity Biotech Fellowship, shares an actionable roadmap for achieving an unlimited healthy lifespan. Topics include strategies for achieving immortality, updating the roadmap and launch strategies, comparative costs and challenges of bioengineering, whole body replacement, and cryostasis, fellowship criteria, critical aspects of longevity, and upcoming Vision Weekends.
The roadmap for achieving an unlimited healthy lifespan focuses on four promising areas in biotech and health extension, including bioengineering, replacement technologies, pharmacology, and acceleration.
The development of tools for bioengineering and treating aging poses challenges and requires significant advancements, highlighting the need for further research and collaboration.
Deep dives
Actionable Roadmap for Unlimited Healthy Lifespan
Mark Hamelain presents an actionable roadmap for achieving an unlimited healthy lifespan. The roadmap focuses on four promising areas for progress in biotech and health extension and highlights the need for a coherent overall vision. Despite the lack of a credible plan for addressing aging, there are numerous roadmaps and theories in the field. The absence of a clear plan hinders progress, attracts limited talent, and fosters a fragmented approach. The LDF aims to develop a roadmap through extensive expert interviews, categorizing strategies, and identifying critical projects. The roadmap explores bioengineering, replacement technologies, pharmacology, and acceleration as potential approaches for addressing aging.
Challenges and Risks of Bioengineering
Bioengineering, as a solution to aging, poses challenges and risks due to the complexity of the field. The development of tools to engineer biology and treat aging requires significant advancements. The roadmap acknowledges the need for characterizing and understanding aging, as well as developing appropriate tools. However, the estimation of the complexity and cost associated with bioengineering remains challenging. While progress has been made in specific areas, achieving a comprehensive solution to aging demands further research and collaboration.
Exploring Other Approaches: Replacement, Pharmacology, and Acceleration
The roadmap discusses other approaches to combating aging, including replacement, pharmacology, and acceleration. Replacement technologies, such as organ transplantation and brain replacement, provide potential avenues for addressing aging. Pharmacology interventions aim to modulate biological processes, although their effectiveness is limited in achieving a full solution to aging. Acceleration through advancements in artificial intelligence and lab automation also shows promise. However, risks and assumptions exist for each approach, requiring further exploration and systematic planning.
Call to Action and Future Progress
The roadmap highlights the need for coordinated efforts, institutional innovation, and a coherent vision in the longevity community. It emphasizes the importance of measuring progress, attracting funding, and engaging the public. The LDF aims to collaborate, support existing projects, and potentially launch space-exes for longevity. The roadmap is a work in progress, and the LDF plans to gather expert feedback, refine the plan, and prioritize critical projects. Moving forward, the LDF is committed to enabling contributors, fostering collaboration, and propelling progress towards an unlimited healthy lifespan.
Mark Hamalainen is cofounder of the Longevity Biotech Fellowship. His career has progressed from manual bench work in academia, to lab automation at Synthego, to longevity movement building - always seeking better methods and higher leverage ways to accelerate progress.
He shares an actionable roadmap for an unlimited healthy lifespan, divided into four promising areas for progress.
He shares updates and information regarding The Longevity Biotech Fellowship, whose mission is to enable a future where everyone can access a healthy, unlimited lifespan.
Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.
Allison Duettmann
The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".